Document Detail

A case of prolonged seizure after ECT in a patient treated with clomipramine, lithium, L-tryptophan, quetiapine, and thyroxine for major depression.
MedLine Citation:
PMID:  18648320     Owner:  NLM     Status:  MEDLINE    
Electroconvulsive therapy (ECT) is indicated for the treatment of severe treatment refractory depression in many countries. It is associated with a low risk of morbidity and mortality. It is usual for high doses of psychotropic medications to be prescribed concomitantly with ECT, although published data on the interactions of these with ECT is lacking. Here, we present the case of a middle-aged woman on multiple psychotropic medications who went into status epilepticus for 45 minutes after ECT.
James Rucker; Marilyn Cook
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The journal of ECT     Volume:  24     ISSN:  1533-4112     ISO Abbreviation:  J ECT     Publication Date:  2008 Dec 
Date Detail:
Created Date:  2008-12-05     Completed Date:  2009-03-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9808943     Medline TA:  J ECT     Country:  United States    
Other Details:
Languages:  eng     Pagination:  272-4     Citation Subset:  IM    
South London and Maudsley NHS Foundation Trust, London, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antidepressive Agents / adverse effects*,  therapeutic use
Antidepressive Agents, Tricyclic / adverse effects*,  therapeutic use
Antimanic Agents / adverse effects*,  therapeutic use
Antipsychotic Agents / adverse effects*,  therapeutic use
Clomipramine / adverse effects*,  therapeutic use
Combined Modality Therapy
Depressive Disorder, Major / complications*,  drug therapy,  therapy
Dibenzothiazepines / adverse effects*,  therapeutic use
Electroconvulsive Therapy / adverse effects*
Lithium Compounds / adverse effects*,  therapeutic use
Middle Aged
Status Epilepticus / chemically induced,  etiology*,  psychology
Thyroxine / adverse effects*,  therapeutic use
Tryptophan / adverse effects*,  therapeutic use
Reg. No./Substance:
0/Antidepressive Agents; 0/Antidepressive Agents, Tricyclic; 0/Antimanic Agents; 0/Antipsychotic Agents; 0/Dibenzothiazepines; 0/Lithium Compounds; 0/quetiapine; 303-49-1/Clomipramine; 73-22-3/Tryptophan; 7488-70-2/Thyroxine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Knowledge and attitudes regarding electroconvulsive therapy among medical students and the general p...
Next Document:  Immune reconstitution inflammatory syndrome of the brain: case illustrations of a challenging entity...